ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides

Overview

Journal Int J Hematol Oncol Stem Cell Res

Specialty Hematology

Date 2019 Feb 19

PMID 30774834

Citations 6

Authors

Negin Shokrgozar

Gholamhossein Tamaddon

Affiliations

Soon will be listed here.

Abstract

Hematopoietic stem cell transplantation (HSCT) is a useful treatment. In contrast to solid organ transplantations, the use of ABO blood group mismatch is acceptable in HSCT. Immediate or late hemolytic reactions, pure red cell aplasia, delayed red blood cell recovery, and graft-versus -host disease are the results of this situation. This review shows the consequences of ABO-mismatched HSCT and its impacts on HSCT parameters, as well as providing clinical guides in this situation.

Citing Articles

Persistent Antigen A after Minor ABO-Incompatible Hematopoietic Stem Cell Transplantation in Children: Two Case Reports.

Andric B, Radonjic Z, Serbic O, Vujic D, Zecevic Z, Simic M Transfus Med Hemother. 2024; 51(6):439-443.

PMID: 39664456 PMC: 11630906. DOI: 10.1159/000536176.

ABO blood groups and galectins: Implications in transfusion medicine and innate immunity.

Arthur C, Hollenhorst M, Wu S, Jajosky R, Nakahara H, Jan H Semin Immunol. 2024; 74-75:101892.

PMID: 39405833 PMC: 11808837. DOI: 10.1016/j.smim.2024.101892.

Hyperbilirubinemia in ABO Minor Mismatch Transplantation.

Liao G, Wei C, Huang Q, Wei M, Li J, Chen Y Mediterr J Hematol Infect Dis. 2024; 16(1):e2024050.

PMID: 38984096 PMC: 11232679. DOI: 10.4084/MJHID.2024.050.

ABO incompatibility haploidentical peripheral blood stem cell transplantation combined with a single cord blood unit for severe aplastic anemia patients.

Wang X, Wang Y, Saulat A, Liu R, Ren J, Zhu H SAGE Open Med. 2024; 12:20503121241255807.

PMID: 38826828 PMC: 11143862. DOI: 10.1177/20503121241255807.

ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies.

Jajosky R, Wu S, Zheng L, Jajosky A, Jajosky P, Josephson C iScience. 2023; 26(1):105798.

PMID: 36691627 PMC: 9860303. DOI: 10.1016/j.isci.2022.105798.

References

Benjamin R, McGurk S, Ralston M, Churchill W, Antin J . ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion. 1999; 39(2):179-87. DOI: 10.1046/j.1537-2995.1999.39299154733.x. View

Lee J, Lee K, Kim S, Lee J, Kim S, Kwon S . Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000; 25(2):179-84. DOI: 10.1038/sj.bmt.1702121. View

Worel N, Greinix H, Schneider B, Kurz M, Rabitsch W, Knobl P . Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion. 2000; 40(5):543-50. DOI: 10.1046/j.1537-2995.2000.40050543.x. View

Rowley S, Liang P, Ulz L . Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplant. 2000; 26(7):749-57. DOI: 10.1038/sj.bmt.1702572. View

Bolan C, Childs R, Procter J, Barrett A, Leitman S . Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol. 2001; 112(3):787-95. DOI: 10.1046/j.1365-2141.2001.02587.x. View

Bolan C, Leitman S, Griffith L, Wesley R, Procter J, Stroncek D . Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood. 2001; 98(6):1687-94. DOI: 10.1182/blood.v98.6.1687. View

Rowley S . Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs. Bone Marrow Transplant. 2001; 28(4):315-21. DOI: 10.1038/sj.bmt.1703135. View

Labar B, Bogdanic V, Nemet D, Mrsic M, Pavletic Z, Zupancic-Salek S . Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant. Bone Marrow Transplant. 1992; 10(5):471-2. View

Verholen F, Stalder M, Helg C, Chalandon Y . Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. Eur J Haematol. 2004; 73(6):441-6. DOI: 10.1111/j.1600-0609.2004.00320.x. View

10.

Achermann F, Julmy F, Gilliver L, Carrel T, Nydegger U . Soluble type A substance in fresh-frozen plasma as a function of ABO and Secretor genotypes and Lewis phenotype. Transfus Apher Sci. 2005; 32(3):255-62. DOI: 10.1016/j.transci.2004.05.007. View

11.

Petz L . Immune hemolysis associated with transplantation. Semin Hematol. 2005; 42(3):145-55. DOI: 10.1053/j.seminhematol.2005.05.017. View

12.

Helbig G, Stella-Holowiecka B, Krawczyk-Kulis M, Wojnar J, Markiewicz M, Wojciechowska-Sadus M . Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia. Haematologica. 2005; 90 Suppl:ECR33. View

13.

Seebach J, Stussi G, Passweg J, Loberiza Jr F, Gajewski J, Keating A . ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant. 2005; 11(12):1006-13. DOI: 10.1016/j.bbmt.2005.07.015. View

14.

Helbig G, Stella-Holowiecka B, Wojnar J, Krawczyk M, Krzemien S, Wojciechowska-Sadus M . Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies. Ann Hematol. 2007; 86(9):677-83. DOI: 10.1007/s00277-007-0304-8. View

15.

Worel N, Greinix H, Supper V, Leitner G, Mitterbauer M, Rabitsch W . Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning. Transfusion. 2007; 47(8):1494-502. DOI: 10.1111/j.1537-2995.2007.01289.x. View

16.

Yazer M, Triulzi D . Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation. Curr Opin Hematol. 2007; 14(6):664-70. DOI: 10.1097/MOH.0b013e3282e9a576. View

17.

Janatpour K, Kalmin N, Jensen H, Holland P . Clinical outcomes of ABO-incompatible RBC transfusions. Am J Clin Pathol. 2008; 129(2):276-81. DOI: 10.1309/VXY1ULAFUY6E6JT3. View

18.

Fang B, Song Y, Li N, Li J, Han Q, Zhao R . Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation. Ann Hematol. 2008; 88(3):261-6. DOI: 10.1007/s00277-008-0599-0. View

19.

Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S . Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica. 2008; 93(11):1686-93. DOI: 10.3324/haematol.12933. View

20.

Malomgre W, Neumeister B . Recent and future trends in blood group typing. Anal Bioanal Chem. 2008; 393(5):1443-51. DOI: 10.1007/s00216-008-2411-3. View